Faith Osier
Faith Osier
Executive Director, IAVI Human Immunology Laboratory, Imperial College London
Adresse e-mail validée de
Citée par
Citée par
Breadth and Magnitude of Antibody Responses to Multiple Plasmodium falciparum Merozoite Antigens Are Associated with Protection from Clinical Malaria
FHA Osier, G Fegan, SD Polley, L Murungi, F Verra, KKA Tetteh, B Lowe, ...
Infection and immunity 76 (5), 2240-2248, 2008
Stable and unstable malaria hotspots in longitudinal cohort studies in Kenya
P Bejon, TN Williams, A Liljander, AM Noor, J Wambua, E Ogada, A Olotu, ...
PLoS medicine 7 (7), e1000304, 2010
The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody
AD Douglas, AR Williams, JJ Illingworth, G Kamuyu, S Biswas, ...
Nature communications 2 (1), 1-9, 2011
Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against malaria
MJ Boyle, L Reiling, G Feng, C Langer, FH Osier, H Aspeling-Jones, ...
Immunity 42 (3), 580-590, 2015
Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria
FHA Osier, G Feng, MJ Boyle, C Langer, J Zhou, JS Richards, ...
BMC medicine 12 (1), 1-15, 2014
HIV infection, malnutrition, and invasive bacterial infection among children with severe malaria
JA Berkley, P Bejon, T Mwangi, S Gwer, K Maitland, TN Williams, ...
Clinical infectious diseases 49 (3), 336-343, 2009
Changes in malaria epidemiology in Africa and new challenges for elimination
IN Nkumama, WP O’Meara, FHA Osier
Trends in parasitology 33 (2), 128-140, 2017
New antigens for a multicomponent blood-stage malaria vaccine
FH Osier, MJ Mackinnon, C Crosnier, G Fegan, G Kamuyu, M Wanaguru, ...
Science translational medicine 6 (247), 247ra102-247ra102, 2014
Recent insights into humoral and cellular immune responses against malaria
JG Beeson, FHA Osier, CR Engwerda
Trends in parasitology 24 (12), 578-584, 2008
Prognostic indicators of early and late death in children admitted to district hospital in Kenya: cohort study
JA Berkley, A Ross, I Mwangi, FHA Osier, M Mohammed, M Shebbe, ...
Bmj 326 (7385), 361, 2003
Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coast
S Borrmann, P Sasi, L Mwai, M Bashraheil, A Abdallah, S Muriithi, ...
PloS one 6 (11), e26005, 2011
Abnormal blood glucose concentrations on admission to a rural Kenyan district hospital: prevalence and outcome
FHA Osier, JA Berkley, A Ross, F Sanderson, S Mohammed, C Newton
Archives of Disease in Childhood 88 (7), 621-625, 2003
Malaria eradication and elimination: views on how to translate a vision into reality
M Tanner, B Greenwood, CJM Whitty, EK Ansah, RN Price, AM Dondorp, ...
BMC medicine 13 (1), 1-22, 2015
Haemoglobin C and S role in acquired immunity against Plasmodium falciparum malaria
F Verra, J Simpore, GM Warimwe, KK Tetteh, T Howard, FHA Osier, ...
PloS one 2 (10), e978, 2007
A library of functional recombinant cell-surface and secreted P. falciparum merozoite proteins
C Crosnier, M Wanaguru, B McDade, FH Osier, K Marsh, JC Rayner, ...
Molecular & Cellular Proteomics 12 (12), 3976-3986, 2013
Fraction of all hospital admissions and deaths attributable to malnutrition among children in rural Kenya
P Bejon, S Mohammed, I Mwangi, SH Atkinson, F Osier, N Peshu, ...
The American journal of clinical nutrition 88 (6), 1626-1631, 2008
Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions
RO Payne, SE Silk, SC Elias, K Miura, A Diouf, F Galaway, H De Graaf, ...
JCI insight 2 (21), 2017
Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular …
SH Hodgson, E Juma, A Salim, C Magiri, D Kimani, D Njenga, A Muia, ...
Frontiers in microbiology 5, 686, 2014
Naturally acquired antibodies to polymorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3
FHA Osier, SD Polley, T Mwangi, B Lowe, DJ Conway, K Marsh
Parasite immunology 29 (8), 387-394, 2007
A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria
LM Murungi, G Kamuyu, B Lowe, P Bejon, M Theisen, SM Kinyanjui, ...
Vaccine 31 (37), 3936-3942, 2013
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20